Pulmonx Corporation

Healthcare · Medical Devices · United States

Last price 3.165 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 135.93M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with mult...